These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

348 related articles for article (PubMed ID: 30920453)

  • 1. Treatment of primary and secondary immune thrombocytopenia.
    Kado R; McCune WJ
    Curr Opin Rheumatol; 2019 May; 31(3):213-222. PubMed ID: 30920453
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Retrospective analysis of rituximab therapy and splenectomy in childhood chronic and refractory immune thrombocytopenic purpura.
    Ay Y; Karapinar TH; Oymak Y; Toret E; Demirag B; Ince D; Ozcan E; Moueminoglou N; Koker SA; Vergin C
    Blood Coagul Fibrinolysis; 2016 Jun; 27(4):431-5. PubMed ID: 26656905
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Splenectomy in ITP: we keep removing a healthy functional organ.
    Anguita E; Candel FJ; González-Del Castillo J; Martín-Sánchez FJ
    Ann Hematol; 2016 Oct; 95(11):1911-2. PubMed ID: 27577110
    [No Abstract]   [Full Text] [Related]  

  • 4. [Differential diagnosis and therapy of immune thrombocytopenia].
    Giagounidis A
    Dtsch Med Wochenschr; 2024 Aug; 149(15):895-903. PubMed ID: 39013410
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Retrospective Evaluation of Survival and Prognostic Factors in Immune Thrombocytopenia: A Single-Center and Cross-Sectional Study.
    Pektaş G; Uncu İA; Dere Y; Öncü Ş; Kızılkaya MB; Sadi G; Pektaş MB
    Medicina (Kaunas); 2024 Jul; 60(7):. PubMed ID: 39064581
    [No Abstract]   [Full Text] [Related]  

  • 6. Mechanisms of platelet recovery in ITP associated with therapy.
    Pang SJ; Lazarus AH
    Ann Hematol; 2010 Jul; 89 Suppl 1():31-5. PubMed ID: 20179926
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and tolerability of old and new drugs used in the treatment of immune thrombocytopenia: Results from a long-term observation in clinical practice.
    Depré F; Aboud N; Mayer B; Salama A
    PLoS One; 2018; 13(6):e0198184. PubMed ID: 29856800
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of acute immune thrombocytopenic purpura.
    Tarantino MD; Goldsmith G
    Semin Hematol; 1998 Jan; 35(1 Suppl 1):28-35. PubMed ID: 9523747
    [TBL] [Abstract][Full Text] [Related]  

  • 9. First-line therapies for immune thrombocytopenic purpura: re-evaluating the need to treat.
    Rodeghiero F
    Eur J Haematol Suppl; 2008 Feb; (69):19-26. PubMed ID: 18211569
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Treatment outcome of immune thrombocytopenia].
    Iványi JL; Marton E; Plander M
    Orv Hetil; 2012 Oct; 153(41):1613-21. PubMed ID: 23045311
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is splenectomy necessary for immune thrombocytopenic purpura? The role of rituximab in patients with corticosteroid resistance in a single-center experience.
    Zhang C; Liu HF; Chen XH; Gao L; Gao L; Liu Y; Kong PY; Sun AH; Zhang X
    Clin Ther; 2014 Mar; 36(3):385-8. PubMed ID: 24594069
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of immune thrombocytopenic purpura in children : current concepts.
    Shad AT; Gonzalez CE; Sandler SG
    Paediatr Drugs; 2005; 7(5):325-36. PubMed ID: 16220997
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current and emerging treatments for immune thrombocytopenia.
    Dou X; Yang R
    Expert Rev Hematol; 2019 Sep; 12(9):723-732. PubMed ID: 31237783
    [No Abstract]   [Full Text] [Related]  

  • 14. Epidemiology, pathophysiology, and initial management of chronic immune thrombocytopenic purpura.
    Pruemer J
    Am J Health Syst Pharm; 2009 Jan; 66(2 Suppl 2):S4-10. PubMed ID: 19139489
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Splenectomy Outcomes in Relapsed or Refractory Immune Thrombocytopenia according to First-Line Intravenous Immunoglobulin Response.
    Kwag D; Yoon JH; Min GJ; Park SS; Park S; Lee SE; Cho BS; Eom KS; Kim YJ; Kim HJ; Lee S; Min CK; Cho SG; Kim DW; Lee JW
    Acta Haematol; 2022; 145(5):465-475. PubMed ID: 35016175
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Idiopathic thrombocytopenic purpura (ITP) in children].
    Rajantie J
    Duodecim; 2011; 127(19):2081-6. PubMed ID: 22073540
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current management of adult idiopathic thrombocytopenic purpura in practice: a cohort study of 201 patients from a single center.
    Zimmer J; Andrès E; Noel E; Koumarianou A; Blicklé JF; Maloisel F
    Clin Lab Haematol; 2004 Apr; 26(2):137-42. PubMed ID: 15053808
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of chronic immune thrombocytopenic purpura in children and adults.
    Blanchette V; Freedman J; Garvey B
    Semin Hematol; 1998 Jan; 35(1 Suppl 1):36-51. PubMed ID: 9523748
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immune thrombocytopenic purpura - current management practices.
    Sandler SG; Tutuncuoglu SO
    Expert Opin Pharmacother; 2004 Dec; 5(12):2515-27. PubMed ID: 15571469
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of idiopathic thrombocytopenic purpura (ITP) in patients with refractoriness to or with contraindication for corticosteroids and/or splenectomy with immunosuppressive therapy and danazol.
    Schiavotto C; Castaman G; Rodeghiero F
    Haematologica; 1993; 78(6 Suppl 2):29-34. PubMed ID: 8039755
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.